arrow
R

Robin J. Gunn

mirati therapeutics, inc.
H指数:12
被引数:1,760

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Discovery of ORIC-944, a novel inhibitor of PRC2 with best-in-class properties for the treatment of prostate cancer
2024-04-050
PRE
Discovery of Pyridopyrimidinones that Selectively Inhibit the H1047R PI3Kα Mutant Protein
2024-03-133
OAAI
Discovery of Five SOS2 Fragment Hits with Binding Modes Determined by SOS2 X-Ray Cocrystallography

通过SOS2 x射线共晶法确定的结合模式发现了五个SOS2片段命中

2023-12-291
OAAI
Anti-tumor efficacy of a potent and selective non-covalent KRASG12D inhibitor

一种有效的选择性非共价KRASG12D抑制剂的抗肿瘤功效

2022-10-10207
OA
Design and Discovery of MRTX0902, a Potent, Selective, Brain- Penetrant, and Orally Bioavailable Inhibitor of the SOS1:KRAS Protein-Protein Interaction

MRTX0902的设计和发现,SOS1:KRAS蛋白-蛋白相互作用的有效,选择性,脑渗透性和口服生物利用度抑制剂

2022-07-1450
OAAI
Fragment-Based Discovery of MRTX1719, a Synthetic Lethal Inhibitor of the PRMT5•MTA Complex for the Treatment of MTAP-Deleted Cancers
2022-01-1876
OA
Identification of MRTX1133, a Noncovalent, Potent, and Selective KRASG12D Inhibitor

鉴定非共价,有效和选择性的KRASG12D抑制剂MRTX1133

2021-12-10354
OA